Aspirin (DL-lysine)
Aspirin DL-lysine (ASA DL-lysine) is a lysine-containing aspirin derivative. Aspirin DL-lysine inhibits cyclooxygenase (COX) in platelets, blocks the synthesis of thromboxane A2 (TXA2), and thus inhibits platelet aggregation and activation. Aspirin DL-lysine can be used to study thrombin generation in patients with unstable angina pectoris[1].
Product Specifications
CAS Number
62952-06-1
Product Name Alternative
Acetylsalicylic acid (DL-lysine) ; ASA (DL-lysine)
UNSPSC
12352005
Hazard Statement
H302
Target
COX; NF-κB; p38 MAPK
Type
Reference compound
Related Pathways
Immunology/Inflammation; MAPK/ERK Pathway; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease; Others
Assay Protocol
https://www.medchemexpress.com/aspirin-dl-lysine.html
Smiles
O=C(C1=C(OC(C)=O)C=CC=C1)O.O=C(C(CCCCN)N)O
Molecular Formula
C15H22N2O6
Molecular Weight
326.34
Precautions
P264-P270-P330-P501
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 8/18 (C-51), CF740 conjugate, 0.1mg/mL
